Dailiport 3mg modified-release capsules
BNF presentation 0802020T0BKACAT within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0802020T0BKACAT
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
5
NHS spend (£)
£859.10
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 3 |
| December 2024 | 1 |
| October 2024 | 1 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |